Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

SAVASAVA

Showing 8 of 30 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in FILANA THERAPEUTICS INC

Yes. Northern Trust holds 114,322 shares of SAVA (Filana Therapeutics), worth $136,043, as of its Q2 2026 13F filing. It reduced the position by 34,872 shares (-23.4%) from Q1 2026. Northern Trust has held SAVA in every 13F on record since Q1 2019, 30 quarterly filings.

Current Value

$136,043

Current Shares

114,322

Total Value Change

-$11.5M

Total Shares Change

-281,458

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
114,322
-23.4%
$136,0430.0%$1.19
0
2026-Q1
Unchanged
149,194
0.0%
$252,1380.0%$1.69
0
2025-Q4
Increased
149,194
+13.7%
$295,4050.0%$1.98
18
2025-Q3
Increased
131,170
+29.0%
$381,7050.0%$2.91
20
2025-Q2
Decreased
101,675
-72.5%
$184,0320.0%$1.81
0
2025-Q1
Decreased
369,090
-9.2%
$553,6360.0%$1.50
0
2024-Q4
Increased
406,562
+2.7%
$959,4870.0%$2.36
26
2024-Q3
Increased
395,780
+4.6%
$11.6M0.0%$29.43
29

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used